Publication | Open Access

Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice

ObesityMetabolic SyndromeMedicineInsulin ManagementDiabetesPhysiologyEarly AdministrationHypothalamic PeptideOb/ob MiceEndocrinologyPharmacologyRelated Metabolic AbnormalitiesInsulin SignalingGastrointestinal Peptide HormoneHealth Sciences